| Michael Wang |
| Affiliation |
UTMD Anderson Cancer Center |
| Country |
United States |
| Google Scholar ID |
vb7bdy0AAAAJ |
| Documents |
20 |
| Citations |
60,383 |
| h-index |
114 |
| Subject Area |
Hematology |
| Event |
Global Scientist Day Awards |
Michael Wang
UTMD Anderson Cancer Center
Michael Wang is a physician-scientist whose work has significantly influenced the clinical management and translational understanding of hematologic malignancies, particularly lymphoma and mantle cell lymphoma. His academic career combines clinical investigation, therapeutic innovation, and multidisciplinary collaboration aimed at improving patient outcomes through evidence-based medicine. His scholarly publications, extensive citation record, and sustained research productivity have established his work as an important reference within hematology and oncology research communities.[1]
Abstract
Michael Wang has contributed extensively to clinical hematology through research focused on lymphoid malignancies, targeted therapeutics, immunotherapy, precision medicine, and translational oncology. His investigations have supported the development and evaluation of innovative treatment strategies while advancing the scientific understanding of disease biology. The substantial academic influence reflected by his citation metrics demonstrates broad utilization of his published findings by clinicians and researchers worldwide.[1][2]
Keywords
Hematology, Mantle Cell Lymphoma, Clinical Oncology, Targeted Therapy, Immunotherapy, Precision Medicine, Translational Research, Clinical Trials, Blood Cancer, Evidence-Based Medicine
Introduction
Modern hematology increasingly relies on interdisciplinary collaboration, molecular diagnostics, and targeted therapeutic development. Researchers working at the interface of laboratory science and clinical medicine play an essential role in translating biological discoveries into effective patient care. Michael Wang has participated in this evolving landscape by contributing to research involving lymphoma diagnosis, treatment optimization, and evaluation of emerging therapeutic approaches that continue to shape international clinical practice.[2]
Research Profile
As a clinician-investigator affiliated with UTMD Anderson Cancer Center, Michael Wang has developed a research portfolio emphasizing hematologic cancers, translational oncology, investigator-led clinical trials, and therapeutic innovation. His scholarly record demonstrates sustained engagement in collaborative research, publication of peer-reviewed scientific literature, and mentorship within academic medicine.[1]
Publications
The available scholarly profile indicates twenty indexed publications with extensive citation activity exceeding sixty thousand citations. These publications include original investigations, clinical studies, reviews, and collaborative research addressing hematologic cancers and targeted therapeutic interventions.[1]
Research Impact
An h-index of 114 reflects sustained scholarly influence across numerous publications and demonstrates that Michael Wang’s research has been widely referenced throughout biomedical literature. Such impact suggests continuing relevance of his investigations in clinical decision-making, therapeutic innovation, and academic research related to hematologic oncology.[1]
Award Suitability
Based on publicly available scholarly indicators, Michael Wang demonstrates characteristics commonly associated with distinguished scientific recognition, including influential publications, exceptional citation performance, interdisciplinary collaboration, clinical research leadership, and measurable contributions to hematology. These accomplishments align with the objectives of the Global Scientist Day Awards in recognizing researchers whose work advances scientific knowledge and benefits healthcare through sustained academic excellence.[1][3]
Conclusion
Michael Wang represents an established researcher in hematology whose academic achievements encompass clinical innovation, translational research, and influential scientific publication. His sustained research impact, international visibility, and commitment to improving treatment strategies for hematologic malignancies support recognition within programs celebrating excellence in global scientific research.[1]
External Links
References
- Google Scholar. (n.d.). Author profile: Michael Wang.
https://scholar.google.com/citations?user=vb7bdy0AAAAJ&hl=en&oi=sra
- New England Journal of Medicine. (2015). Clinical research in hematologic malignancies.
https://doi.org/10.1056/NEJMoa1412676
- Global Scientist Day Awards. (n.d.). Award information and scientific recognition program.
https://scientistday.org/